FLT3 and acute myeloid leukemia: Importantly, FLT3 mutations are prognostically relevant in pediatric AML, and the presence of ITD particularly with an high allelic ratio (AR) of ≥0.5 have a prognostic impact and are significant predictive factors for an adverse outcome (12–14).